日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720

MSP2-C1 是一种含有两种 MSP2 同工酶的血液期疟疾疫苗,采用 Montanide® ISA 720 配制而成,目前正在进行 I 期临床试验。

McCarthy, James S; Marjason, Joanne; Elliott, Suzanne; Fahey, Paul; Bang, Gilles; Malkin, Elissa; Tierney, Eveline; Aked-Hurditch, Hayley; Adda, Christopher; Cross, Nadia; Richards, Jack S; Fowkes, Freya J I; Boyle, Michelle J; Long, Carole; Druilhe, Pierre; Beeson, James G; Anders, Robin F

Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity

同时或先后接种减毒活日本脑炎嵌合病毒疫苗和黄热病17D疫苗:随机双盲II期安全性和免疫原性评价

Nasveld, Peter E; Marjason, Joanne; Bennett, Sonya; Aaskov, John; Elliott, Suzanne; McCarthy, Karen; Kanesa-Thasan, Niranjan; Feroldi, Emmanuel; Reid, Mark

Safety and immunogenicity of an oral inactivated whole-cell pseudomonas aeruginosa vaccine administered to healthy human subjects

对健康人体受试者进行口服灭活全细胞铜绿假单胞菌疫苗的安全性和免疫原性研究

Cripps, Allan W; Peek, Keith; Dunkley, Margaret; Vento, Kevin; Marjason, Joanne K; McIntyre, Madonna E; Sizer, Phil; Croft, Duncan; Sedlak-Weinstein, Lis